World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
124
Citations
64417
World Ranking
3195
National Ranking
29

Research.com Recognitions

  • 2019 - IEEE Fellow For contributions to magnetic information storage and spintronic devices

Overview

Ching-Lung Lai is affiliated with the University of Hong Kong in China. Their research primarily spans the field of Medicine, with a strong focus on epidemiology, infectious diseases, oncology, hepatology, and neurology. The scope of their work includes clinical and laboratory studies related to liver diseases and viral infections.

The scientist's key topics of study cover various aspects of viral hepatitis and COVID-19, including:

  • Hepatitis B Virus Studies
  • Liver Disease Diagnosis and Treatment
  • COVID-19 Clinical Research Studies
  • Hepatitis C Virus Research
  • Long-Term Effects of COVID-19
  • SARS-CoV-2 and COVID-19 Research
  • Vaccine Coverage and Hesitancy

Frequent collaboration partners for Ching-Lung Lai include:

  • Zhipeng Yan
  • Ming Yang
  • Man-Fung Yuen
  • Danny Ka-Ho Wong
  • Lung-Yi Mak

The scientist has published multiple papers in notable venues, with priorities in liver disease and viral infections. Key venues where their work appears include:

  • Journal of Hepatology
  • Biomedicines
  • Pharmaceuticals
  • Cell Death Discovery
  • Clinical Infectious Diseases

Recent significant publications include:

  • Long COVID-19 Syndrome: A Comprehensive Review of Its Effect on Various Organ Systems and Recommendation on Rehabilitation Plans (2021, Biomedicines)
  • COVID-19 Vaccines: A Review of the Safety and Efficacy of Current Clinical Trials (2021, Pharmaceuticals)
  • Combination treatments including the small-interfering RNA JNJ-3989 induce rapid and sometimes prolonged viral responses in patients with CHB (2022, Journal of Hepatology)
  • SARS-CoV-2 infection: can ferroptosis be a potential treatment target for multiple organ involvement? (2020, Cell Death Discovery)
  • Effect of Antiviral Treatment on Hepatitis B Virus Integration and Hepatocyte Clonal Expansion (2022, Clinical Infectious Diseases)

Ching-Lung Lai has been recognized with the IEEE Fellow award in 2019 for contributions to magnetic information storage and spintronic devices. This honor reflects a notable achievement within the scientific community, although it lies somewhat outside the primary focus of their medical research.

Best Publications

  • Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update.

    S. K. Sarin;M. Kumar;G. K. Lau;Z. Abbas

  • A One-Year Trial of Lamivudine for Chronic Hepatitis B

    C.-L. Lai;R.-N. Chien;N. W. Y. Leung;T.-T. Chang

  • Viral hepatitis B

    Ching Lung Lai;Vlad Ratziu;Man-Fung Yuen;Thierry Poynard

  • Entecavir versus Lamivudine for Patients with HBeAg-Negative Chronic Hepatitis B

    Ching Lung Lai;Daniel Shouval;Anna S. Lok;Ting Tsung Chang

  • Sofosbuvir and Velpatasvir for HCV Genotype 1, 2, 4, 5, and 6 Infection

    Jordan J. Feld;Ira M. Jacobson;Christophe Hézode;Tarik Asselah

  • Viral hepatitis C

    Thierry Poynard;Man-Fung Yuen;Vlad Ratzin;Ching Lung Lai

  • Long‐term entecavir therapy results in the reversal of fibrosis/cirrhosis and continued histological improvement in patients with chronic hepatitis B

    Ting Tsung Chang;Yun Fan Liaw;Shun Sheng Wu;Eugene Schiff

  • Long-term safety of lamivudine treatment in patients with chronic hepatitis B.

    Anna S.F. Lok;Ching Lung Lai;Nancy Leung;Guang Bi Yao

  • Telbivudine versus lamivudine in patients with chronic hepatitis B.

    Ching-Lung Lai;Edward Gane;Yun-Fan Liaw;Chao-Wei Hsu

  • Effects of extended lamivudine therapy in Asian patients with chronic hepatitis B

    Y.-F. Liaw;N. W. Y. Leung;T.-T. Chang;R. Guan

  • Extended lamivudine treatment in patients with chronic hepatitis B enhances hepatitis B e antigen seroconversion rates: Results after 3 years of therapy

    Nancy W. Y. Leung;Ching-Lung Lai;Ting-Tsung Chang;Richard Guan

  • 2-Year GLOBE Trial Results: Telbivudine Is Superior to Lamivudine in Patients With Chronic Hepatitis B

    Yun–Fan Liaw;Edward Gane;Nancy Leung;Stefan Zeuzem

  • Prevalence and Clinical Correlates of YMDD Variants during Lamivudine Therapy for Patients with Chronic Hepatitis B

    Ching Lung Lai;Jules Dienstag;Eugene Schiff;Nancy W.Y. Leung

  • Hepatitis B virus infection

    Man-Fung Yuen;Ding-Shinn Chen;Ding-Shinn Chen;Geoffrey M. Dusheiko;Harry L. A. Janssen

  • Lansoprazole for the prevention of recurrences of ulcer complications from long-term low-dose aspirin use

    Kam Chuen Lai;Shiu Kum Lam;Kent Man Chu;Benjamin C Y Wong

  • Adult-to-adult living donor liver transplantation using extended right lobe grafts.

    Chung-mau Lo;Sheung-tat Fan;Chi-leung Liu;William I. Wei

  • Entecavir treatment for up to 5 years in patients with hepatitis b e antigen-positive chronic hepatitis B

    Ting Tsung Chang;Ching Lung Lai;Seung Kew Yoon;Samuel S. Lee

  • Independent risk factors and predictive score for the development of hepatocellular carcinoma in chronic hepatitis B

    Man-Fung Yuen;Yasuhito Tanaka;Daniel Yee-Tak Fong;James Fung

  • A comparison of fibrosis progression in chronic liver diseases

    Thierry Poynard;Philippe Mathurin;Ching-Lung Lai;Dominique Guyader

  • A 1-Year Trial of Telbivudine, Lamivudine, and the Combination in Patients With Hepatitis B e Antigen—Positive Chronic Hepatitis B

    Ching-Lung Lai;Nancy Leung;Eng-Kiong Teo;Myron Tong

Frequent Co-Authors

Man-Fung Yuen
Man-Fung Yuen University of Hong Kong
Chung Mau Lo
Chung Mau Lo University of Hong Kong
Yasuhito Tanaka
Yasuhito Tanaka Kumamoto University
Benjamin C.Y. Wong
Benjamin C.Y. Wong University of Hong Kong
Sheung Tat Fan
Sheung Tat Fan University of Hong Kong
Irene Oi-Lin Ng
Irene Oi-Lin Ng University of Hong Kong
Ivan Hung
Ivan Hung University of Hong Kong
Robert G. Gish
Robert G. Gish University of Nevada Reno
Masashi Mizokami
Masashi Mizokami National Center For Global Health and Medicine
Johnson Y.N. Lau
Johnson Y.N. Lau Hong Kong Baptist University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a career in medicine opens doors to diverse and rewarding educational paths. Many students today consider flexible online programs that allow them to advance their skills and credentials while balancing work and other commitments.

For those interested in health and wellness, an online bachelor's in nutrition provides a solid foundation in dietary science and can lead to roles in healthcare, education, or food service industries.

Aspiring healthcare administrators may pursue online mha programs cahme accredited, which ensure rigorous standards and prepare graduates for leadership roles in hospitals, clinics, and public health organizations.

Registered nurses looking to advance can benefit from rn to bsn online without clinicals programs. These options streamline the process, letting working RNs earn a bachelor’s degree without traditional onsite clinical requirements.

For nurses seeking the highest level of clinical expertise, the fastest dnp online program options enable rapid progression to doctorate-level skills, empowering advanced practice and leadership in healthcare settings.

Best Scientists Citing Ching-Lung Lai

Trending Scientists